The renoprotection effects of Spironolactone through inhibiting MCP-l mRNA expression of renal tissue in STZ-induced type 2 diabetic rats

Zhang Li,Li Sumei,Ye Shandong
DOI: https://doi.org/10.3969/j.issn.1000-7377.2010.01.003
2010-01-01
Abstract:Objective:To investigate the renoprotective effects of Spironolactone and its influence on the expression of MCP-1mRNA in kidney tissue and urinary MCP-1 excretion of diabetic rats. Methods:The peripheral blood glucose and HbA1c were measured at the 8th week.At the 8th week,the urinary excretion rates of albumin(ALB),retinal-binding protein(RBP)and monocyte chemoattractant protein-1(MCP-1) were tested and relative kidney index was calculated.The renal tissues of diabetic rats were obtained for RT-PCR to examine the gene expression of MCP-1 in renal tissue.Results:①The blood glucose levels and HbAlc at the 8th week in groups D and S were significant higher than those in group C at the same period;②At the 8th week,not only the urinary excretion rates of ALB,RBP and MCP-1,but also the relative kidney index were markedly increased in groups D and S compared with group C.However,the parameters above in groups C were much lower than those in group D.In addition,the urinary excretion of MCP-1 was positively correlated to the urinary excretion,the urinary RBP excretion and relative kidney index;③ In comparison with group C,the expression of MCP-1mRNA was significantly up-regulated in group D and group S;the expression of MCP-1 mRNA in group S was reduced markedly compared with that in group D. Conclusion:Spironolactone has renoprotective effects through down-regulating the over-expression of MCP-1 mRNA in renal tissue and reducing urinary excretion of MCP-1 in STZ-induced diabetic rats.
What problem does this paper attempt to address?